Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Core High Dividend ETF (HDV) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

iShares Core High Dividend ETFTrade
Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

iShares Core High Dividend ETF vs Intuitive Surgical, Inc. — how do they compare? iShares Core High Dividend ETF trades at $29.03, while Intuitive Surgical, Inc. trades at $401.06 (market cap $141.75B). The key difference: iShares Core High Dividend ETF is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals.

HDVISRG
52-Week High
$29.14$592.85
52-Week Low
$23.64$332.02
Market Cap
$141.75B
Sector
Health
Enterprise Value
$136.53B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Core High Dividend ETF

HDV trades at $28.92, down 0.24% on the day, with a bullish technical signal supported by moving averages. The ETF focuses on high-quality dividend stocks, offering a 3.1% yield and outperforming the S&P 500 year-to-date by 9 percentage points according to 24/7 Wall Street on July 23, 2026. Recent institutional buying includes Bay Colony Advisory Group increasing its position by 370.7% in Q2 2026.

The outlook remains positive for income investors seeking stable dividends from large-cap US companies. Key risks include interest rate sensitivity and sector concentration in defensive stocks. Institutional accumulation and strong technical momentum support continued investor interest in this dividend-focused ETF.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $393.38, up 3.85% on the day, with a bullish technical signal and strong earnings momentum, having beaten EPS estimates for three consecutive quarters. The stock exhibits premium valuation metrics, including a P/E of 46.01 and P/S of 13.08, supported by robust revenue growth, which reached $10.06B in 2025, and high net income margins of 28.45%. Recent news highlights analyst upgrades and optimism around the da Vinci 5 system's adoption.

The outlook remains positive given durable demand and innovation, but risks include heightened competition and valuation sensitivity. Wall Street consensus is bullish with a $518.10 price target, implying significant upside, though investors should weigh premium multiples against growth sustainability and competitive pressures in the medtech space.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About iShares Core High Dividend ETF

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is comprised of qualified income paying securities that are screened for superior company quality and financial health as determined by Morningstar, Inc.'s proprietary index methodology. The fund is non-diversified.

Read more on HDV

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG